A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation

PHASE3CompletedINTERVENTIONAL

Enrollment

118

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 1998

Conditions

Conduct DisorderDisruptive Behavior DisorderOppositional Defiant Disorder

Interventions

DRUG

risperidone

All Listed Sponsors

lead

Janssen Pharmaceutica N.V., Belgium

INDUSTRY